WO2001052860A3 - Method and composition for modulating an immune response - Google Patents
Method and composition for modulating an immune response Download PDFInfo
- Publication number
- WO2001052860A3 WO2001052860A3 PCT/US2001/001678 US0101678W WO0152860A3 WO 2001052860 A3 WO2001052860 A3 WO 2001052860A3 US 0101678 W US0101678 W US 0101678W WO 0152860 A3 WO0152860 A3 WO 0152860A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- modulating
- composition
- immune response
- inhibitors
- antiporter
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001229601A AU2001229601A1 (en) | 2000-01-24 | 2001-01-18 | Method and composition for modulating an immune response |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49188800A | 2000-01-24 | 2000-01-24 | |
US09/491,888 | 2000-01-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001052860A2 WO2001052860A2 (en) | 2001-07-26 |
WO2001052860A3 true WO2001052860A3 (en) | 2002-06-20 |
Family
ID=23954080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/001678 WO2001052860A2 (en) | 2000-01-24 | 2001-01-18 | Method and composition for modulating an immune response |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001229601A1 (en) |
WO (1) | WO2001052860A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2043650A2 (en) | 2006-07-14 | 2009-04-08 | Medical Research Council | Treatment for demyelinating disease |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5260275A (en) * | 1990-08-14 | 1993-11-09 | Amylin Pharmaceuticals, Inc. | Hypoglycemics |
EP0688766A1 (en) * | 1994-06-20 | 1995-12-27 | Hoechst Aktiengesellschaft | Phenylsubstituted alkenyl-carboxylic-acid-guanidines containing perfluoroalkyl groups, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them |
WO1996009823A1 (en) * | 1994-09-28 | 1996-04-04 | Shaman Pharmaceuticals, Inc. | Hypoglycemic agent from cryptolepis |
EP0749751A2 (en) * | 1995-06-20 | 1996-12-27 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition for use in tteatment of diabetes |
WO1997017975A1 (en) * | 1995-11-14 | 1997-05-22 | Abiogen Pharma S.R.L. | A glibenclamide-metformin combination for the treatment of diabetes mellitus of type ii |
WO1998056378A1 (en) * | 1997-06-13 | 1998-12-17 | Novo Nordisk A/S | Novel niddm regimen |
WO1999018932A1 (en) * | 1997-10-15 | 1999-04-22 | Edward Mendell Co., Inc. | Novel once-a-day controlled release sulfonylurea formulation |
WO1999037151A1 (en) * | 1998-01-23 | 1999-07-29 | Board Of Regents, The University Of Texas System | Method and compositions for promotion of wound healing |
-
2001
- 2001-01-18 WO PCT/US2001/001678 patent/WO2001052860A2/en active Application Filing
- 2001-01-18 AU AU2001229601A patent/AU2001229601A1/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5260275A (en) * | 1990-08-14 | 1993-11-09 | Amylin Pharmaceuticals, Inc. | Hypoglycemics |
EP0688766A1 (en) * | 1994-06-20 | 1995-12-27 | Hoechst Aktiengesellschaft | Phenylsubstituted alkenyl-carboxylic-acid-guanidines containing perfluoroalkyl groups, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them |
WO1996009823A1 (en) * | 1994-09-28 | 1996-04-04 | Shaman Pharmaceuticals, Inc. | Hypoglycemic agent from cryptolepis |
EP0749751A2 (en) * | 1995-06-20 | 1996-12-27 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition for use in tteatment of diabetes |
WO1997017975A1 (en) * | 1995-11-14 | 1997-05-22 | Abiogen Pharma S.R.L. | A glibenclamide-metformin combination for the treatment of diabetes mellitus of type ii |
WO1998056378A1 (en) * | 1997-06-13 | 1998-12-17 | Novo Nordisk A/S | Novel niddm regimen |
WO1999018932A1 (en) * | 1997-10-15 | 1999-04-22 | Edward Mendell Co., Inc. | Novel once-a-day controlled release sulfonylurea formulation |
WO1999037151A1 (en) * | 1998-01-23 | 1999-07-29 | Board Of Regents, The University Of Texas System | Method and compositions for promotion of wound healing |
Non-Patent Citations (2)
Title |
---|
DUNNING B E: "NATEGLINIDE: A GLUCOSE-SENSITIVE INSULINOTROPIC AGENT THAT IS CHEMICALLY AND PHARMACOLOGICALLY DISTINCT FROM THE SULFONYLUREAS", CURRENT OPINION IN ENDOCRINOLOGYAND DIABETES, PHILADELPHIA, PA, US, vol. 6, no. SUPPL 1, August 1999 (1999-08-01), pages S29 - S31, XP000997507, ISSN: 1068-3097 * |
PERFETTI R ET AL: "NOVEL THERAPEUTIC STRATEGIES FOR THE TREATMENT OF TYPE 2 DIABETES", DIABETES/METABOLISM REVIEWS, WILEY, NEW YORK, NY, US, vol. 14, no. 3, 1998, pages 207 - 225, XP000908775, ISSN: 0742-4221 * |
Also Published As
Publication number | Publication date |
---|---|
AU2001229601A1 (en) | 2001-07-31 |
WO2001052860A2 (en) | 2001-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1023767A1 (en) | Substituted pyridines as selective cyclooxygenase-2 inhibitors and the composition thereof. | |
AU2002300903A1 (en) | Game monitoring system, game playing table and monitoring method | |
AU2001227586A1 (en) | Application report and method for creating the same | |
ZA981132B (en) | Methods, compositions and articles for reducing or preventing the effects of inflammation. | |
AU4956297A (en) | Raf kinase inhibitors | |
AU2002214597A1 (en) | Methods and systems for analyzing the motion of sporting equipment | |
GB2386177B (en) | Refrigerator and method for controlling the same | |
AU1869792A (en) | Heat sink, method of manufacturing the same, and device of manufacturing the same | |
AU4624899A (en) | Magnetic coating, coating method using said coating and implementing device | |
AU2002225894A1 (en) | Methods and compositions for the control of coccidiosis | |
AU2002238899A1 (en) | Temperature fluctuation cooking method, and refrigerator | |
AU2002357180A1 (en) | Timing system and device and method for making the same | |
EP1262264A4 (en) | Thrust converter, and method and device for controlling the thrust converter | |
EP1383017A4 (en) | Automatic lathe, method for controlling the same, and device for controlling the same | |
AU7874698A (en) | Luminescent tool, its auxiliary member and method of preserving biotool and the auxiliary member | |
EP1383018A4 (en) | Automatic lathe, and method for controlling the same and device for controlling the same | |
BR9400180A (en) | Disc valve without return | |
WO2001052860A3 (en) | Method and composition for modulating an immune response | |
AU2002366898A1 (en) | Method and control system for the voice control of an appliance | |
ZA992394B (en) | C11 Oxymyl and hydroxyamino prostaglandins useful as FP agonists. | |
AU2001244461A1 (en) | Venous line catheter and method of operating the same | |
AU2001243594A1 (en) | Sorber, its method of making and its use | |
GB2334100A8 (en) | Chromogenic substrates, media and methods for the detection of salmonella spp. | |
AU4226299A (en) | Prenyl transferase inhibitors | |
AU1719700A (en) | Selective inhibitors of mmp-12 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |